Related references
Note: Only part of the references are listed.Novel proteasome-inhibitory syrbactin analogs inducing endoplasmic reticulum stress and apoptosis in hematological tumor cell lines
Ashish Anshu et al.
BIOCHEMICAL PHARMACOLOGY (2011)
The natural product hybrid of Syringolin A and Glidobactin A synergizes proteasome inhibition potency with subsite selectivity
Jerome Clerc et al.
CHEMICAL COMMUNICATIONS (2011)
Specific Cell-Permeable Inhibitor of Proteasome Trypsin-like Sites Selectively Sensitizes Myeloma Cells to Bortezomib and Carfilzomib
Anne C. Mirabella et al.
CHEMISTRY & BIOLOGY (2011)
Proteasome Activity Imaging and Profiling Characterizes Bacterial Effector Syringolin A
Izabella Kolodziejek et al.
PLANT PHYSIOLOGY (2011)
Syrbactin class proteasome inhibitor-induced apoptosis and autophagy occurs in association with p53 accumulation and Akt/PKB activation in neuroblastoma
Crystal R. Archer et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Evaluation of the Proteasome Inhibitor MLN9708 in Preclinical Models of Human Cancer
Erik Kupperman et al.
CANCER RESEARCH (2010)
Activity-Based Profiling Reveals Reactivity of the Murine Thymoproteasome-Specific Subunit β5t
Bogdan I. Florea et al.
CHEMISTRY & BIOLOGY (2010)
Convergent Synthesis and Biological Evaluation of Syringolin A and Derivatives as Eukaryotic 20S Proteasome Inhibitors
Jerome Clerc et al.
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2010)
Nature of Pharmacophore Influences Active Site Specificity of Proteasome Inhibitors
Michael Screen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Incorporation of Fluorinated Phenylalanine Generates Highly Specific Inhibitor of Proteasome's Chymotrypsin-like Sites
Paul P. Geurink et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Pseudomonas syringae Virulence Factor Syringolin A Counteracts Stomatal Immunity by Proteasome Inhibition
Barbara Schellenberg et al.
MOLECULAR PLANT-MICROBE INTERACTIONS (2010)
Antimicrobial nucleoside antibiotics targeting cell wall assembly: Recent advances in structure-function studies and nucleoside biosynthesis
Michael Winn et al.
NATURAL PRODUCT REPORTS (2010)
A panel of subunit-selective activity-based proteasome probes
Martijn Verdoes et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2010)
Total Synthesis of Syringolin A and B
Michael C. Pirrung et al.
ORGANIC LETTERS (2010)
Total Synthesis of Syringolin A
Chunhui Dai et al.
ORGANIC LETTERS (2010)
Syringolin A Selectively Labels the 20 S Proteasome in Murine EL4 and Wild-Type and Bortezomib-Adapted Leukaemic Cell Lines
Jerome Clerc et al.
CHEMBIOCHEM (2009)
Synthesis and Structure-Activity Correlation of a Brunsvicamide-Inspired Cyclopeptide Collection
Thilo Walther et al.
CHEMBIOCHEM (2009)
Selective Inhibitor of Proteasome's Caspase-like Sites Sensitizes Cells to Specific Inhibition of Chymotrypsin-like Sites
Matthew Britton et al.
CHEMISTRY & BIOLOGY (2009)
A Phase 1 Dose Escalation Study of the Safety and Pharmacokinetics of the Novel Proteasome Inhibitor Carfilzomib (PR-171) in Patients with Hematologic Malignancies
Owen A. O'Connor et al.
CLINICAL CANCER RESEARCH (2009)
Design and Synthesis of an Orally Bioavailable and Selective Peptide Epoxyketone Proteasome Inhibitor (PR-047)
Han-Jie Zhou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Synthetic and structural studies on syringolin A and B reveal critical determinants of selectivity and potency of proteasome inhibition
Jerome Clerc et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Synthesis and evaluation of a new class of tertiary alcohol based BACE-1 inhibitors
Francesco Russo et al.
TETRAHEDRON (2009)
A plant pathogen virulence factor inhibits the eukaryotic proteasome by a novel mechanism
Michael Groll et al.
NATURE (2008)
CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib
Roberto Piva et al.
BLOOD (2008)
Mixing of peptides and electrophilic traps gives rise to potent, broad-spectrum proteasome inhibitors
Martijn Verdoes et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2007)
20S proteasome and its inhibitors: Crystallographic knowledge for drug development
Ljudmila Borissenko et al.
CHEMICAL REVIEWS (2007)
Syringolin A, a new plant elicitor from the phytopathogenic bacterium Pseudomonas syringae pv. syringae, inhibits the proliferation of neuroblastoma and ovarian cancer cells and induces apoptosis
C. S. Coleman et al.
CELL PROLIFERATION (2006)
A novel series of urea-based peptidomimetic calpain inhibitors
ML Sanders et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome
M Groll et al.
STRUCTURE (2006)
A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib
D Chauhan et al.
CANCER CELL (2005)
Exploring the stereochemical requirements for protease inhibition by ureidopeptides
BS Barth et al.
JOURNAL OF PEPTIDE RESEARCH (2005)
Facile incorporation of urea pseudopeptides into protease substrate analogue inhibitors
AC Myers et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
A convenient and scaleable procedure for removing the Fmoc group in solution
JE Sheppeck et al.
TETRAHEDRON LETTERS (2000)
Share Paper
